Sunridge International's Business Plan is Ahead of Schedule

FOUNTAIN HILLS, Ariz., April 28 /PRNewswire-FirstCall/ -- Sunridge International (OTC Bulletin Board: SNDZ), announced today that it is moving rapidly to expand its distribution network worldwide. Mr. Smith, Sunridge International's CEO, states that "the company was going to focus on expanding its distributor network for its treatment of glaucoma and ocular hypertension known as Pneumatic Trabeculoplasty (PNT). This was to be our main drive. We are only four months into the year, yet we are negotiating with both individuals and companies for at least ten new areas around the world. We should be opening new distributors in Europe, Asia, Central and South America this year."

Mr. Smith goes on to say, that "every time we move into a new area it causes interest in the surrounding countries. As more people experience the benefits of this cost effective, non-invasive, alternative treatment, the more the word spreads, and new distributor interest follows. As we add distributors we automatically increase sales for our PNT device and the disposable product line used in the treatment. The company is already experiencing record sales for the first four months, largely due to the marketing roll out of PNT in China, after receiving approval from the State Food and Drug Administration in February."

Mr. Smith states that "this is just the start and that we are going to work hard to keep the momentum going."

SOURCE Sunridge International